138 related articles for article (PubMed ID: 8217597)
1. Characterisation of a new mouse monoclonal antibody (ONS-M21) reactive with both medulloblastomas and gliomas.
Moriuchi S; Shimizu K; Miyao Y; Hayakawa T
Br J Cancer; 1993 Nov; 68(5):831-7. PubMed ID: 8217597
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody ONS-M21 recognizes integrin alpha3 in gliomas and medulloblastomas.
Kishima H; Shimizu K; Tamura K; Miyao Y; Mabuchi E; Tominaga E; Matsuzaki J; Hayakawa T
Br J Cancer; 1999 Jan; 79(2):333-9. PubMed ID: 9888477
[TBL] [Abstract][Full Text] [Related]
3. Internalization with high targeting potential of mouse monoclonal antibody ONS-M21 recognizing human malignant glioma antigen.
Shimizu K; Park KC; Tamura K; Kishima H; Kawata H; Yoshimura Y; Sekimori Y; Miyao Y; Hayakawa T
Cancer Lett; 1998 May; 127(1-2):171-6. PubMed ID: 9619874
[TBL] [Abstract][Full Text] [Related]
4. Production and characterization of two human glioma xenograft-localizing monoclonal antibodies.
Wikstrand CJ; McLendon RE; Bullard DE; Fredman P; Svennerholm L; Bigner DD
Cancer Res; 1986 Nov; 46(11):5933-40. PubMed ID: 3756930
[TBL] [Abstract][Full Text] [Related]
5. Five new epitope-defined monoclonal antibodies reactive with GM2 and human glioma and medulloblastoma cell lines.
Vrionis FD; Wikstrand CJ; Fredman P; Månsson JE; Svennerholm L; Bigner DD
Cancer Res; 1989 Dec; 49(23):6645-51. PubMed ID: 2479468
[TBL] [Abstract][Full Text] [Related]
6. Phenotyping of 60 cultured human gliomas and 34 other neuroectodermal tumors by means of monoclonal antibodies against glioma, melanoma and HLA-DR antigens.
de Muralt B; de Tribolet N; Diserens AC; Stavrou D; Mach JP; Carrel S
Eur J Cancer Clin Oncol; 1985 Feb; 21(2):207-16. PubMed ID: 2985398
[TBL] [Abstract][Full Text] [Related]
7. Humanization of mouse ONS-M21 antibody with the aid of hybrid variable regions.
Ohtomo T; Tsuchiya M; Sato K; Shimizu K; Moriuchi S; Miyao Y; Akimoto T; Akamatsu K; Hayakawa T; Ohsugi Y
Mol Immunol; 1995 Apr; 32(6):407-16. PubMed ID: 7753049
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody T-199 directed against human medulloblastoma: characterization of a new antigenic system expressed on neuroectodermal tumors and natural killer cells.
Feickert HJ; Pietsch T; Hadam MR; Mildenberger H; Riehm H
Cancer Res; 1989 Aug; 49(15):4338-43. PubMed ID: 2743322
[TBL] [Abstract][Full Text] [Related]
9. Five novel cell surface antigens of CNS neoplasms.
Jennings MT; Jennings VD; Asadourian LL; Rosenblum M; Albino AP; Cairncross JG; Old LJ
J Neurol Sci; 1989 Jan; 89(1):63-78. PubMed ID: 2926443
[TBL] [Abstract][Full Text] [Related]
10. Expression of neuroectodermal antigens common to melanomas, gliomas, and neuroblastomas. I. Identification by monoclonal anti-melanoma and anti-glioma antibodies.
Carrel S; de Tribolet N; Mach JP
Acta Neuropathol; 1982; 57(2-3):158-64. PubMed ID: 6181646
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody 8H9 targets a novel cell surface antigen expressed by a wide spectrum of human solid tumors.
Modak S; Kramer K; Gultekin SH; Guo HF; Cheung NK
Cancer Res; 2001 May; 61(10):4048-54. PubMed ID: 11358824
[TBL] [Abstract][Full Text] [Related]
12. Production and characterization of a monoclonal antibody against medulloblastoma-derived cell line.
Tatsumi S; Kokunai T; Tamaki N
Neurol Med Chir (Tokyo); 1996 May; 36(5):277-85. PubMed ID: 8710049
[TBL] [Abstract][Full Text] [Related]
13. Characterization of neuroectodermal antigen by a monoclonal antibody and its application in CSF diagnosis of human glioma.
Wakabayashi T; Yoshida J; Seo H; Kazo K; Murata Y; Matsui N; Kageyama N
J Neurosurg; 1988 Mar; 68(3):449-55. PubMed ID: 3343615
[TBL] [Abstract][Full Text] [Related]
14. Reactivity of antiglioma monoclonal antibodies for a large panel of cultured gliomas and other neuroectoderm derived tumors.
de Muralt B; de Tribolet N; Diserens AC; Carrel S; Mach JP
Anticancer Res; 1983; 3(1):1-6. PubMed ID: 6830147
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody UJ 127:11 detects a 220,000-240,000 kdal. glycoprotein present on a sub-set of neuroectodermally derived cells.
Kemshead JT; Fritschy J; Garson JA; Allan P; Coakham H; Brown S; Asser U
Int J Cancer; 1983 Feb; 31(2):187-95. PubMed ID: 6826247
[TBL] [Abstract][Full Text] [Related]
16. A humanized single-chain Fv fragment with high targeting potential against human malignant gliomas.
Ohtomo T; Kawata H; Sekimori Y; Shimizu K; Kishima H; Moriuchi S; Miyao Y; Akamatsu K; Tsuchiya M
Anticancer Res; 1998; 18(6A):4311-5. PubMed ID: 9891484
[TBL] [Abstract][Full Text] [Related]
17. [Autoimmune response in the serum of patients with cerebral gliomas].
González C; Fumanal FJ; Roda JE
Rev Clin Esp; 1984 Apr; 173(1):45-7. PubMed ID: 6739896
[No Abstract] [Full Text] [Related]
18. Human glioma-specific antigens detected by monoclonal antibodies.
Kondo S; Miyatake S; Iwasaki K; Oda Y; Kikuchi H; Zu Y; Shamoto M; Namba Y
Neurosurgery; 1992 Apr; 30(4):506-11. PubMed ID: 1584348
[TBL] [Abstract][Full Text] [Related]
19. Calbindin-D28k in subsets of medulloblastomas and in the human medulloblastoma cell line D283 Med.
Katsetos CD; Herman MM; Krishna L; Vender JR; Vinores SA; Agamanolis DP; Schiffer D; Burger PC; Urich H
Arch Pathol Lab Med; 1995 Aug; 119(8):734-43. PubMed ID: 7646332
[TBL] [Abstract][Full Text] [Related]
20. Immunolocalization of monoclonal antibody-defined extracellular matrix antigens in human brain tumors.
McComb RD; Bigner DD
J Neurooncol; 1985; 3(2):181-6. PubMed ID: 4031975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
